Ocular Complications From Cancer Therapy - Patient Registry and Biobank
Recruiting now
Conditions studied: Graft Versus Host Disease in Eye, Ocular Complications, Inflammatory Dry Eye Disease
In brief
The purpose of this study is to collect data on patients seen at University of Maryland after undergoing cancer therapy. Previous medications, ocular history, medical history, clinical evaluations, surgical procedures and outcomes will be gathered on the patients who consent to participate. Potential subjects will be enrolled from the clinical practice of the investigator at the time of their eye examination visit. A standard of care exam will be performed pertinent to the reason for the visit. In addition to the standard of care exam, certain biological specimens (ocular surface wash, mucocellular material, corneal filaments, impression cytology, and/or blood) will be collected, stored, and analyzed to obtain immunologic, cellular, or molecular mechanistic insights into disease pathogenesis.
Key facts
- Study ID
- NCT06874283
- Run by
- University of Maryland, Baltimore
- People needed
- 150
- Starts
- 2025-05-13
- Expected to finish
- 2031-04-01
- Last updated by the study team
- 2026-03-05
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
Where it is running
- Stoler Outpatient Cancer Center at the University of Maryland — Baltimore, Maryland, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.